NanoViricides Inc (NNVC)

NanoViricides Inc (NNVC) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 26, 2026: market cap $33.2M; returns 1 day -2.9%, 1 week +4.6%, 1 year -11.1%.

NanoViricides, Inc. (NNVC) is a clinical-stage biopharmaceutical company focused on developing broad-spectrum antiviral drugs using its proprietary Nanoviricide platform technology. Incorporated in 1997, the company's operational focus began in 2005.

Groups NNVC belongs to

• Biotechnology
• Clinical Stage Biopharma
• Clinical Stage
• Pharmaceuticals
• Antivirals
• Infectious Diseases
• Biopharmaceutical
• COVID-19

NNVC financial model: income statement, cash flow and balance sheet